K-pop

SM Entertainment Signs MOU with Musinsa… "To Strengthen Marketing Cooperation"

Co-CEO Tak Young-jun: "We Will Provide a New IP Experience"

KIM HYUNSIK
2026-09-14 16:03:34
[Edaily Starin KIM HYUNSIK Reporter] SM Entertainment (SM) announced on the 14th that it has signed a memorandum of understanding (MOU) with the fashion and beauty platform Musinsa to strengthen marketing cooperation.
Tak Young-jun, Co-CEO of SM Entertainment (right), and Choi Jae-young, CCO (Chief Commerce Officer) of Musinsa, pose for a commemorative photo after the signing ceremony at SM’s headquarters in Seongsu-dong, Seoul, on the 14th. (Photo courtesy of SM Entertainment)
The signing ceremony, held that day at SM’s headquarters in Seongsu-dong, Seoul, was attended by approximately 10 representatives from both companies, including Tak Young-jun, Co-CEO of SM, and Choi Jae-young, CCO (Chief Commerce Officer) of Musinsa.
Under this agreement, SM will provide artist intellectual property (IP), and Musinsa will provide online and offline media support. The two companies will also collaborate on content development and expanding into key global markets.
Previously, SM and Musinsa collaborated on new product campaigns and pop-up stores to celebrate the release of new albums by the girl group Hearts to Hearts and the boy group NCT 127.
Tak Young-joon, co-CEO of SM, stated, “We will pursue branding collaborations with Musinsa across various areas—including album pop-ups, content, music releases, and media—to provide new IP experiences.”

Economy

Corporation

IT·Science

Economy

[Market In] Turning to Bank Loans Instead of Corporate Bonds… Will Even A-Rated Companies Turn Their Backs on the Bond Market Next Year?

The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
2026-11-14 16:05:05

Corporation

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
2026-11-14 12:47:03

IT·Science

“The Era of 1.5 Million Robots”… The Korean Company JP Morgan Has Singled Out

A forecast indicates that U.S. production of humanoid robots will reach up to 400,000 units by 2030 and 1.5 million units by 2035. Analysts predict that as the humanoid robot industry moves beyond tec…
2026-11-14 08:36:21